As well as the activin focus, other aims included applying the results from pathology and clinical testing, with and without activin B, to the pattern recognition algorithm random forest (RF), to identify wider marker patterns that separate ME/CFS cases from healthy controls. The gene discussed is INHBE; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.